Gem Aromatics / Q3-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Watch2026-02-10Back to GEMAROMA

Revenue

₹78.9 Cr

verified against source

Revenue YoY

reported change

EBITDA

₹7 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
1 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q3 FY26: -5 · Watch source sentiment · 2026-02-10Q3 FY26-5-5
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Gem Aromatics reported Q3 FY26 consolidated revenue of ₹78.9 crore with an EBITDA margin of 8.9%, impacted by tariff uncertainties and GST changes. Gross margins improved to 23% from 14% QoQ, driven by better mint prices and clove derivative growth. The new Dahej facility (Crystal Ingredients) was commissioned on December 11, 2025, with cooling agents and eugenol verticals operational; contribution was limited to ~20 days. Management guided for ₹1,050-1,100 crore revenue by FY28 with 16-18% EBITDA margins, driven by Dahej ramp-up and product diversification. Dahej is expected to reach 50-60% utilization by Q1 FY28 and peak revenue of ₹750-800 crore by FY29. Near-term risks include persistent tariff headwinds and GST-related demand disruption in the domestic market.

Colored figures show movement against the previous available record.

Guidance to track

  • Company targets consolidated revenue of ₹1,050-1,100 crore by FY28, with Dahej contributing ~₹700 crore and Gem ~₹400 crore.
  • Management expects consolidated EBITDA margins to reach 16-18% by FY28, driven by Dahej's margin-accretive products and operational efficiencies.
  • Dahej plant expected to reach 50-60% capacity utilization by Q1 FY28, with all products online by Q1 FY27.
  • Crystal Ingredients expected to achieve cash break-even at roughly 45% capacity utilization during FY27.

Risks flagged

  • 60% of exports were to the US, and tariffs continue to impact demand. Management is pursuing a US+1 strategy but due diligence is lengthy.
  • GST changes have led to cautious procurement, especially from price-sensitive unorganized players. Clarity is emerging but impact lingers.
  • New facility requires customer approvals and production stability; delays in commercialization could impact revenue targets.

Key quotes

  • The company is targeting revenue of rupees 1050 to 1100 crores by FI28 with Ibida margins in the range of 16 to 18%.
  • We expect crystal to break even in the next year.
  • A large portion of our business is with sticky customers and this portfolio... the numbers of the top five customers pretty much have not changed in the last decade.

Research modules

Go one layer deeper.